Furthermore, aberrant receptor tyrosine kinase signaling, commonly observed in NSCLC, can indirectly activate Akt-mTOR through upstream signaling cascades [14, 43, 47]. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.